Literature DB >> 19545912

Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1beta and IL-1 receptor antagonist in the ischemic cortex.

Jin A Shin1, Eun-Mi Park, Ji-Seung Choi, Sun-Mi Seo, Jihee Lee Kang, Kyung-Eun Lee, Sunghee Cho.   

Abstract

Ischemic preconditioning (IP) is a phenomenon that organs develop a tolerance toward subsequent lethal ischemic insults. Among the factors that are involved in IP, IL-1beta and its endogenous receptor antagonist IL-1ra have been identified as important players in the induction of IP. The present study investigated whether IP affects the levels of these two antagonistic proteins during tolerance and reperfusion periods after ischemic stroke. The IP 24 h prior to ischemic stroke resulted in neuroprotection in the cortex. IP-induced protection is accompanied by increased IL-1beta gene and IL-1ra gene and protein levels during the tolerance period. In the post-ischemic cortex, IP resulted in the suppression of IL-1beta mRNA and protein levels at 6 h without affecting IL-1ra expression and the up-regulation of IL-1ra protein at 24 h. These findings demonstrate that IP differentially regulates cortical IL-1beta and IL-1ra expression before and after ischemic stroke and suggest that the shift toward an anti-inflammatory state in the post-ischemic cortex may contribute to IP-induced neuroprotection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19545912      PMCID: PMC2916648          DOI: 10.1016/j.jneuroim.2009.06.001

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  36 in total

1.  Prevention of inflammation is a mechanism of preconditioning-induced neuroprotection against focal cerebral ischemia.

Authors:  Kellie K Bowen; Michelle Naylor; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2006-06-06       Impact factor: 3.921

Review 2.  Cerebral preconditioning and ischaemic tolerance.

Authors:  Jeffrey M Gidday
Journal:  Nat Rev Neurosci       Date:  2006-06       Impact factor: 34.870

3.  Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons.

Authors:  T Ohtsuki; C A Ruetzler; K Tasaki; J M Hallenbeck
Journal:  J Cereb Blood Flow Metab       Date:  1996-11       Impact factor: 6.200

4.  Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat.

Authors:  S A Loddick; N J Rothwell
Journal:  J Cereb Blood Flow Metab       Date:  1996-09       Impact factor: 6.200

5.  Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats.

Authors:  Y Yamasaki; N Matsuura; H Shozuhara; H Onodera; Y Itoyama; K Kogure
Journal:  Stroke       Date:  1995-04       Impact factor: 7.914

6.  Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats.

Authors:  T N Lin; Y Y He; G Wu; M Khan; C Y Hsu
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

7.  Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain.

Authors:  A L Betz; G Y Yang; B L Davidson
Journal:  J Cereb Blood Flow Metab       Date:  1995-07       Impact factor: 6.200

8.  The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia.

Authors:  D Martin; N Chinookoswong; G Miller
Journal:  Exp Neurol       Date:  1994-12       Impact factor: 5.330

Review 9.  Interleukin-1 and neuronal injury.

Authors:  Stuart M Allan; Pippa J Tyrrell; Nancy J Rothwell
Journal:  Nat Rev Immunol       Date:  2005-08       Impact factor: 53.106

10.  Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia.

Authors:  Emmanuel Pinteaux; Nancy J Rothwell; Herve Boutin
Journal:  Glia       Date:  2006-04-01       Impact factor: 7.452

View more
  16 in total

Review 1.  14-3-3gamma and neuroglobin are new intrinsic protective factors for cerebral ischemia.

Authors:  Yan Dong; Rui Zhao; Xiao Qian Chen; Albert Cheung Hoi Yu
Journal:  Mol Neurobiol       Date:  2010-05-14       Impact factor: 5.590

2.  Different temporal patterns in the expressions of bone morphogenetic proteins and noggin during astroglial scar formation after ischemic stroke.

Authors:  Jin A Shin; Jihee Lee Kang; Kyung-Eun Lee; Eun-Mi Park
Journal:  Cell Mol Neurobiol       Date:  2012-05       Impact factor: 5.046

3.  Cerebrovascular expression of proteins related to inflammation, oxidative stress and neurotoxicity is altered with aging.

Authors:  Debjani Tripathy; Xiangling Yin; Alma Sanchez; Jinhua Luo; Joseph Martinez; Paula Grammas
Journal:  J Neuroinflammation       Date:  2010-10-11       Impact factor: 8.322

4.  Zinc finger protein 667 expression is upregulated by cerebral ischemic preconditioning and protects cells from oxidative stress.

Authors:  Dun Yuan; Jun Huang; Xianrui Yuan; Jie Zhao; Weixi Jiang
Journal:  Biomed Rep       Date:  2013-05-30

5.  Acute and subacute IL-1β administrations differentially modulate neuroimmune and neurotrophic systems: possible implications for neuroprotection and neurodegeneration.

Authors:  Cai Song; Ye Zhang; Yilong Dong
Journal:  J Neuroinflammation       Date:  2013-05-07       Impact factor: 8.322

6.  Monocyte chemoattractant protein-1-deficiency impairs the expression of IL-6, IL-1β and G-CSF after transient focal ischemia in mice.

Authors:  Jan-Kolja Strecker; Jens Minnerup; Burkhard Gess; E Bernd Ringelstein; Wolf-Rüdiger Schäbitz; Matthias Schilling
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

7.  Increased interleukin-1β levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA.

Authors:  Andrea Mayado; Elisa Torres; Maria D Gutierrez-Lopez; Maria I Colado; Esther O'Shea
Journal:  J Neuroinflammation       Date:  2011-11-24       Impact factor: 8.322

8.  Effects of ischemic preconditioning in a pig model of large-for-size liver transplantation.

Authors:  Antonio José Gonçalves Leal; Ana Cristina Aoun Tannuri; Alessandro Rodrigo Belon; Raimundo Renato Nunes Guimarães; Maria Cecília Mendonça Coelho; Josiane de Oliveira Gonçalves; Suellen Serafini; Evandro Sobroza de Melo; Uenis Tannuri
Journal:  Clinics (Sao Paulo)       Date:  2015-02       Impact factor: 2.365

9.  Fetal asphyctic preconditioning modulates the acute cytokine response thereby protecting against perinatal asphyxia in neonatal rats.

Authors:  Evi Vlassaks; Eveline Strackx; Johan Sh Vles; Maria Nikiforou; Pilar Martinez-Martinez; Boris W Kramer; Antonio Wd Gavilanes
Journal:  J Neuroinflammation       Date:  2013-01-26       Impact factor: 8.322

Review 10.  Immune mechanisms in cerebral ischemic tolerance.

Authors:  Lidia Garcia-Bonilla; Corinne Benakis; Jamie Moore; Costantino Iadecola; Josef Anrather
Journal:  Front Neurosci       Date:  2014-03-04       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.